Cetero Research announced it has completed more than 500 diabetes research studies in the past three years for both Type 1 and Type 2 diabetics, including complex clamp studies and studies in Phase I, II, III and IV. Cetero combines both pivotal pharmacokinetic studies and proof-of-concept studies in one study.
“Approximately eight percent of the U.S. population struggles with diabetes, and the numbers continue to grow,” said Dr. Troy McCall, CEO of Cetero Research. “According to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are a record number of diabetes drugs in development to help the 20 million Americans battling this disease every day. We want to help get those treatments through proof-of-concept faster by providing a full range of services to pharmaceutical companies.”
Cetero runs first-in-human, pharmacokinetic, and proof-of concept studies in diabetics across three of its clinical facilities.
In one diabetes study for a global pharmaceutical company, Cetero randomized the first subject about three weeks after screening began. The final one of the 56 subjects was randomized 13 weeks after the first screening.
Cetero maintains recruiting strategies to build their database of potential study participants. These factors ensure studies are fully recruited, and start and conclude on-time. Cetero also works with a large endocrinology physician practice, which provides Cetero and its clients with access to additional patients.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.